{"SPADE_UN_17593": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17593", "Peptide Name": "Galaxamide [L1l;MeLeu2,4P]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LPLPL", "Sequence Length": 5, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C22H36N4O4", "Mass": 551.72, "PI": 5.53, "Net Charge": 0, "Hydrophobicity": 1.64, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents", "Pubmed ID": "35323457", "Reference": "Mar Drugs. 2022 Feb 22;20(3)161.", "Author": "Li D, Liao X, Zhong S, Zhao B, Xu S.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=35323457"}], "Frequent Amino Acids": "LP", "Absent Amino Acids": "ACDEFGHIKMNOQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02152", "Similarity": 1.0, "Sequence": "FCKSLPLPLSVK"}, {"SPADE_ID": "SPADE_N_02523", "Similarity": 1.0, "Sequence": "RRLRPRHQHFPSERPWPKPLPLPLPRPGPRPWPKPLPLPLPRPGLRPWPKPL"}, {"SPADE_ID": "SPADE_N_11903", "Similarity": 1.0, "Sequence": "LPLNTIPRPPYFPGKLPPRGGHLFPPTCVCVRSPCPCDQNWG"}]}}}